Status:
COMPLETED
Post Coronary Artery Bypass Graft (CABG) Study
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclero...
Detailed Description
BACKGROUND: A large number of studies have reported that following CABG, the vessels proximal to the grafts demonstrate accelerated atherosclerosis and the grafts themselves may show progressive obst...
Eligibility Criteria
Men and women between 1 and 11 years post-CABG. Patients had two completely independent saphenous vein grafts that were patent. Patients had an LDL-cholesterol between 130 and 175 with plasma triglycerides below 300 mg/dl.
Key Trial Info
Start Date :
April 1 1987
Trial Type :
INTERVENTIONAL
End Date :
December 1 1998
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000463
Start Date
April 1 1987
End Date
December 1 1998
Last Update
April 14 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.